Windgap Medical: Injecting Simplicity Into Complex Drug Delivery

Injectable formulations are the fastest growing segment in the pharmaceutical industry. According to Precedence Research, the global injectable drug delivery market reached U.S. $561 billion in 2021 and is expected to surpass $1,224 billion by 2030. Given the astounding 40-70% of patients in the US who are noncompliant with their drug regimens, any simplification of administration is a win for patients, caregivers, providers and society at large.5 Recognizing this need, along with the demand for improved patient experience and desire for self-administration, Windgap Medical is disrupting the status quo for dual-chamber drug delivery devices with the development of its latest product platform, the LVDC (Large Volume Dual Chamber) device. Simplify. Automate. Accelerate. Read more >>